Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to change the concentration of amyloid-beta in human
cerebrospinal fluid (CSF) through modulation of the sleep-wake cycle.
Phase:
N/A
Details
Lead Sponsor:
Washington University School of Medicine
Collaborators:
National Institute on Aging (NIA) National Institutes of Health (NIH)